Literature DB >> 31369760

RETRACTED: Oridonin elevates sensitivity of ovarian carcinoma cells to cisplatin via suppressing cisplatin-mediated autophagy.

Yaxian Zhao1, Huanjun Xia2.   

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. Given the comments of Dr Elisabeth Bik regarding this article “… the Western blot bands in all 400+ papers are all very regularly spaced and have a smooth appearance in the shape of a dumbbell or tadpole, without any of the usual smudges or stains. All bands are placed on similar looking backgrounds, suggesting they were copy/pasted from other sources, or computer generated”, the journal requested the authors to provide the raw data. However, the authors were not able to fulfil this request and therefore the Editor-in-Chief decided to retract the article.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Cell autophagy; Cisplatin; Drug resistance; Oridonin; Ovarian carcinoma

Mesh:

Substances:

Year:  2019        PMID: 31369760     DOI: 10.1016/j.lfs.2019.116709

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Oridonin Induces Apoptosis of Laryngeal Carcinoma via Endoplasmic Reticulum Stress.

Authors:  Bo Kou; Yang Yang; Yin-E Bai; Yu-Han Shi; Rui-Xia Gao; Fang-Li Yang; Shao-Qiang Zhang; Wei Liu
Journal:  Cancer Manag Res       Date:  2020-09-11       Impact factor: 3.989

Review 2.  Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Kiavash Hushmandi; Mahshad Kalantari; Reza Mohammadinejad; Tahereh Javaheri; Gautam Sethi
Journal:  Int J Mol Sci       Date:  2020-06-03       Impact factor: 5.923

Review 3.  Terpenoids' anti-cancer effects: focus on autophagy.

Authors:  Chirine El-Baba; Amro Baassiri; Georges Kiriako; Batoul Dia; Sukayna Fadlallah; Sara Moodad; Nadine Darwiche
Journal:  Apoptosis       Date:  2021-07-16       Impact factor: 4.677

4.  Oridonin Promotes Apoptosis and Restrains the Viability and Migration of Bladder Cancer by Impeding TRPM7 Expression via the ERK and AKT Signaling Pathways.

Authors:  Xianping Che; Jiangtao Zhan; Fan Zhao; Zunhe Zhong; Mianchuan Chen; Ruifa Han; Yi Wang
Journal:  Biomed Res Int       Date:  2021-07-05       Impact factor: 3.411

Review 5.  Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance.

Authors:  Xi Liu; Jimin Xu; Jia Zhou; Qiang Shen
Journal:  Genes Dis       Date:  2020-07-05

Review 6.  Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer.

Authors:  Bartosz Mateusz Gąsiorkiewicz; Paulina Koczurkiewicz-Adamczyk; Kamil Piska; Elżbieta Pękala
Journal:  Invest New Drugs       Date:  2020-11-07       Impact factor: 3.850

Review 7.  Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity.

Authors:  Xiang Li; Chuan-Tao Zhang; Wei Ma; Xin Xie; Qun Huang
Journal:  Front Pharmacol       Date:  2021-07-05       Impact factor: 5.810

8.  Selective synergistic anticancer effects of cisplatin and oridonin against human p53-mutant esophageal squamous carcinoma cells.

Authors:  Huiyu Yang; Jie Wang; Suliman Khan; Yuanying Zhang; Kuicheng Zhu; Enhui Zhou; Meiyuan Gong; Bingrong Liu; Quancheng Kan; Qi Zhang
Journal:  Anticancer Drugs       Date:  2022-01-01       Impact factor: 2.248

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.